(deoxycholic acid) injection, is the first and only FDA-approved injectable drug available that contours and improves the appearance of moderate to severe submental fullness, sometimes referred to as a “double chin.” Submental fullness is a common, yet under-treated aesthetic condition that is often resistant to diet and exercise alone and influenced by several factors, including aging, genetics and weight gain.
Dr. Blackledge is the first physicians in the State of Mississippi to be able to offer KYBELLA™ to patients. Dr. Blackledge was trained on the proper technique for administering the treatment in San Francisco.
Each in-office treatment session with KYBELLA™ is typically 15-20 minutes. When injected into subcutaneous fat, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved with KYBELLA™, re-treatment is not expected.